Cottage Street Advisors LLC Sells 572 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Cottage Street Advisors LLC cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 11.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,414 shares of the healthcare conglomerate's stock after selling 572 shares during the period. UnitedHealth Group comprises approximately 1.2% of Cottage Street Advisors LLC's investment portfolio, making the stock its 26th biggest position. Cottage Street Advisors LLC's holdings in UnitedHealth Group were worth $2,233,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of UNH. Howard Capital Management Group LLC bought a new stake in shares of UnitedHealth Group during the third quarter worth $341,000. Principal Financial Group Inc. grew its position in UnitedHealth Group by 11.3% during the 3rd quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock worth $1,039,933,000 after acquiring an additional 180,479 shares during the last quarter. Algert Global LLC acquired a new stake in shares of UnitedHealth Group during the third quarter valued at about $1,763,000. Truvestments Capital LLC increased its stake in shares of UnitedHealth Group by 13.0% in the third quarter. Truvestments Capital LLC now owns 591 shares of the healthcare conglomerate's stock valued at $346,000 after buying an additional 68 shares during the period. Finally, Mirabella Financial Services LLP acquired a new stake in UnitedHealth Group during the 3rd quarter worth approximately $235,000. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Stock Down 0.0 %

Shares of UNH traded down $0.25 during trading hours on Friday, reaching $515.47. The stock had a trading volume of 2,378,211 shares, compared to its average volume of 4,268,981. The company has a market capitalization of $471.51 billion, a price-to-earnings ratio of 33.26, a P/E/G ratio of 1.37 and a beta of 0.62. The firm has a 50-day simple moving average of $508.81 and a 200 day simple moving average of $544.24. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company's revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the previous year, the company posted $5.83 EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.63%. UnitedHealth Group's payout ratio is presently 54.19%.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on UNH. StockNews.com raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. Hsbc Global Res raised UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a report on Friday, January 10th. Cantor Fitzgerald restated an "overweight" rating and set a $700.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Stephens increased their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an "overweight" rating in a research report on Thursday, December 5th. Finally, Barclays reduced their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a research note on Friday, January 17th. Twenty research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of "Buy" and an average price target of $629.32.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company's stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.